This inventor holds 1 USPTO granted patent. Top assignee: The Mclean Hospital Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Cécile Béquin: Innovator in Salvinorin Research
Introduction
Cécile Béquin is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmacology, particularly through his research on salvinorin derivatives. His work focuses on the therapeutic potential of these compounds in treating mood disorders.
Latest Patents
Cécile Béquin holds a patent for "Salvinorin derivatives and uses thereof." This invention features salvinorin compositions that are selective for kappa opioid receptors. The methods outlined in the patent include treating mania using a selective kappa receptor agonist and addressing mood disorders, such as depressive and manic disorders, with salvinorin compositions.
Career Highlights
Cécile Béquin is affiliated with The McLean Hospital Corporation, where he conducts his research. His work has garnered attention for its innovative approach to addressing complex mood disorders through pharmacological means.
Collaborations
Cécile has collaborated with esteemed colleagues, including William A. Carlezon and Bruce M. Cohen. These partnerships have furthered the research and development of salvinorin-based therapies.
Conclusion
Cécile Béquin's contributions to the field of pharmacology, particularly through his patent on salvinorin derivatives, highlight his role as an innovator in mental health treatment. His work continues to pave the way for new therapeutic approaches to mood disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile